Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29 | 41 | 74 | 88 | 322 |
| TOTAL | $82 | $52 | $161 | $129 | $428 |
| Non-Current Assets | |||||
| Investments And Advances | 9,699 | 9,671 | 45,460 | 45,255 | 45,191 |
| TOTAL | $9,699 | $9,671 | $45,460 | $45,255 | $45,191 |
| Total Assets | $9,781 | $9,724 | $45,620 | $45,384 | $45,619 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 599 | 499 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 375 | 379 | 207 | 106 | 6 |
| TOTAL | $1,216 | $1,073 | $736 | $155 | $30 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,087 | 10,877 | 46,866 | 46,737 | 46,737 |
| TOTAL | $11,095 | $10,906 | $46,866 | $46,737 | $46,737 |
| Total Liabilities | $12,310 | $11,980 | $47,602 | $46,891 | $46,767 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,850 | 2,330 | 5,850 | 5,850 | 5,850 |
| Retained earnings | -2,529 | -2,256 | -1,982 | -1,507 | -1,148 |
| TOTAL | $-2,529 | $-2,256 | $-1,982 | $-1,507 | $-1,147 |
| Total Liabilities And Equity | $9,781 | $9,724 | $45,620 | $45,384 | $45,619 |